PMID

Data

Article Title

Organization

Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists.

Tokyo Medical And Dental University

SAR based design of nicotinamides as a novel class of androgen receptor antagonists for prostate cancer.

Chonnam National University

Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange.

The University Of Tokyo

Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators.

Acadia Pharmaceuticals

Novel selective anti-androgens with a diphenylpentane skeleton.

The University Of Tokyo

Synthesis and in vitro activity of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5 alpha-androstan-3-ones as inhibitors of human 5 alpha-reductases and antagonists of the androgen receptor.

Chul Research Center

Novel 6-aryl-1,4-dihydrobenzo[d]oxazine-2-thiones as potent, selective, and orally active nonsteroidal progesterone receptor agonists.

Wyeth Research

Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators.

Bristol-Myers Squibb Research And Development

Ligands with dual vitamin D3-agonistic and androgen-antagonistic activities.

The University Of Tokyo

Novel 5-aryl-1,3-dihydro-indole-2-thiones. potent, orally active progesterone receptor agonists.

Wyeth Research

Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.

Ochanomizu University

Thermodynamic penalty arising from burial of a ligand polar group within a hydrophobic pocket of a protein receptor.

University Of Leeds